Post-earnings recap
Reported
Thu, Feb 6, 2025
EPS actual
$5.32
EPS est.
$5.03
EPS surprise
+5.77%
1-day move
+3.35%
Eli Lilly's strong EPS performance indicates effective cost management and possibly strong demand for its products. The stock's 3.35% increase reflects investor confidence in the company's ability to generate profits. However, the lack of revenue details and future guidance may leave some investors cautious.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $5.32 | N/A | +5.77% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. However, they did not provide specific guidance for future quarters.
We are pleased with our EPS performance this quarter.
Our focus remains on delivering innovative treatments.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—